Saini J S, Garg M K
DDMS, HQ 11 Corp, C/o, 56 APO, Pune.
Classified Specialist (Medicine & Endocrinology), Command Hospital, (Southern Command), Pune.
Med J Armed Forces India. 2001 Jan;57(1):44-6. doi: 10.1016/S0377-1237(01)80090-3. Epub 2011 Jul 21.
Male erectile dysfunction is common and frustrating after the age of forty years. Erectile dysfunction is a cause of misery, relationship difficulties, and significantly reduced quality of life. Sildenafil citrate (Viagra) has shown promising results in recently published clinical trials. Sildenafil is a potent and competitive inhibitor of cGMp specific phosphodiesterase-5, predominant isoenzyme in the human corpus cavernosum. It is effective in erectile dysfunction of diverse origin, however it requires a patent vascular system to be effective. It is not effective in patients with endocrinal impotence, loss of libido, premature ejaculation or infertility. Its main adverse effects are headache, flushing, dyspepsia, diarrhoea, nasal congestion, indigestion, visual disturbances, dizziness and rash. Ventricular tachycardia and acute myocardial infraction have been reported in patients of ischaemic heart disease after consumption of sildenafil. Six deaths have been reported in patients taking nitrates. In India it is likely to be prescribed by a primary care physician without complete evaluation of patient on complaint of impotence. Hence the ethical question of who should prescribe this drug should be addressed by medical fraternity and proper guidelines formulated to avoid misuse of sildenafil. Phosphodiesterase is distributed in nerve, central nervous system, and systemic vasculature, hence long-term effects of drug on these tissues has to be ascertained. It should be made mandatory to report all adverse drug reactions to ADR monitoring centres. It is a wonder for those who require it, but has potentially dangerous adverse effects and drug interactions and hence is and not a wonder pill for all kinds of impotence.
男性勃起功能障碍在40岁之后很常见且令人沮丧。勃起功能障碍是痛苦、人际关系困难以及生活质量显著下降的一个原因。枸橼酸西地那非(万艾可)在最近发表的临床试验中显示出了有前景的结果。西地那非是一种强效且有竞争性的环磷酸鸟苷特异性磷酸二酯酶-5抑制剂,该酶是人类阴茎海绵体中的主要同工酶。它对多种原因引起的勃起功能障碍有效,然而它需要有完整的血管系统才能发挥作用。它对内分泌性阳痿、性欲减退、早泄或不育患者无效。其主要不良反应有头痛、面部潮红、消化不良、腹泻、鼻塞、肠胃不适、视觉障碍、头晕和皮疹。服用西地那非后,缺血性心脏病患者曾有室性心动过速和急性心肌梗死的报告。服用硝酸盐类药物的患者已有6例死亡报告。在印度,初级保健医生可能会在未对阳痿患者进行全面评估的情况下就开这种药。因此,医学团体应该解决谁应该开这种药的伦理问题,并制定适当的指导方针以避免西地那非的滥用。磷酸二酯酶分布于神经、中枢神经系统和全身血管系统,因此必须确定该药物对这些组织的长期影响。向药品不良反应监测中心报告所有药品不良反应应成为强制性规定。对那些有需要的人来说它是个奇迹,但它有潜在的危险不良反应和药物相互作用,因此并非对所有类型的阳痿都是神奇药丸。